Cargando…

Immune gene signatures and tumor intrinsic markers delineate novel immunogenic subtypes of breast cancer

Detalles Bibliográficos
Autores principales:	Miller, Lance D, Chou, Jeff W, Black, Michael A, Print, Cristin G, Jimenez, Eric, Chifman, Julia, Alistar, Angela, Putti, Thomas C, Zhou, Xiaobo, Bedognetti, Davide, Pullikuth, Ashok, Andrechek, Eran, Wang, Ena, Marincola, Francesco M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292554/ http://dx.doi.org/10.1186/2051-1426-2-S3-P256

Ejemplares similares

Conservation of immune gene signatures in solid tumors and prognostic implications
por: Chifman, Julia, et al.
Publicado: (2016)

Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor Types
por: Routh, Eric D., et al.
Publicado: (2020)

Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes
por: Pullikuth, Ashok K., et al.
Publicado: (2021)

Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
por: He, Xiaotian, et al.
Publicado: (2023)

Tumor mutational burden is a determinant of immune-mediated survival in breast cancer
por: Thomas, Alexandra, et al.
Publicado: (2018)

Histological subtypes of mouse mammary tumors reveal conserved relationships to human cancers
por: Hollern, Daniel P., et al.
Publicado: (2018)

Dual roles for immune metagenes in breast cancer prognosis and therapy prediction
por: Alistar, Angela, et al.
Publicado: (2014)

Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome
por: Bedognetti, Davide, et al.
Publicado: (2014)

A collection of annotated and harmonized human breast cancer transcriptome datasets, including immunologic classification
por: Roelands, Jessica, et al.
Publicado: (2018)

Toward the identification of genetic determinants of breast cancer immune responsiveness
por: Simeone, Ines, et al.
Publicado: (2015)

Systems biology approach to studying proliferation-dependent prognostic subnetworks in breast cancer
por: Song, Qianqian, et al.
Publicado: (2015)

HER2/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factors
por: Andrechek, Eran R.
Publicado: (2013)

Conserved E2F mediated metastasis in mouse models of breast cancer and HER2 positive patients
por: Rennhack, Jonathan, et al.
Publicado: (2015)

Transcription factor compensation during mammary gland development in E2F knockout mice
por: To, Briana, et al.
Publicado: (2018)

Delineating conditions and subtypes in chronic pain using neuroimaging
por: Holmes, Scott A., et al.
Publicado: (2019)

The transcriptional landscape of endogenous retroelements delineates esophageal adenocarcinoma subtypes
por: Kazachenka, Anastasiya, et al.
Publicado: (2023)

Mouse models of cancers: opportunities to address heterogeneity of human cancer and evaluate therapeutic strategies
por: Andrechek, Eran R., et al.
Publicado: (2010)

Tyrosine kinase signalling in breast cancer: Tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer
por: Andrechek, Eran R, et al.
Publicado: (2000)

A genomic analysis of mouse models of breast cancer reveals molecular features of mouse models and relationships to human breast cancer
por: Hollern, Daniel P, et al.
Publicado: (2014)

Triple-negative breast cancer and the potential for targeted therapy
por: Jhan, Jing-Ru, et al.
Publicado: (2017)

Stat3 accelerates Myc induced tumor formation while reducing growth rate in a mouse model of breast cancer
por: Jhan, Jing-Ru, et al.
Publicado: (2016)

Low E2F2 activity is associated with high genomic instability and PARPi resistance
por: Rennhack, Jonathan P., et al.
Publicado: (2020)

Metastasis is altered through multiple processes regulated by the E2F1 transcription factor
por: Swiatnicki, Matthew R., et al.
Publicado: (2021)

Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South Africa
por: Alistar, Sabina S, et al.
Publicado: (2014)

Context-specific gene regulatory networks subdivide intrinsic subtypes of breast cancer
por: Nasser, Sara, et al.
Publicado: (2011)

Diverse Developmental Disorders from The One Ring: Distinct Molecular Pathways Underlie the Cohesinopathies
por: Horsfield, Julia A., et al.
Publicado: (2012)

GeneSetDB: A comprehensive meta-database, statistical and visualisation framework for gene set analysis
por: Araki, Hiromitsu, et al.
Publicado: (2012)

A phylogenetic approach to inferring the order in which mutations arise during cancer progression
por: Gao, Yuan, et al.
Publicado: (2022)

Molecular Characterization and Landscape of Breast cancer Models from a multi-omics Perspective
por: Ortiz, Mylena M.O., et al.
Publicado: (2023)

PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis
por: Boons, Gitta, et al.
Publicado: (2020)

Arbitrary-order intrinsic virtual element method for elliptic equations on surfaces
por: Bachini, Elena, et al.
Publicado: (2021)

Intrinsic subtypes and bladder cancer metastasis
por: McConkey, David J., et al.
Publicado: (2016)

Biclustering reveals breast cancer tumour subgroups with common clinical features and improves prediction of disease recurrence
por: Wang, Yi Kan, et al.
Publicado: (2013)

Tumor-intrinsic determinants of immunogenic cell death modalities
por: Workenhe, Samuel T, et al.
Publicado: (2021)

A Zebrafish Model of Roberts Syndrome Reveals That Esco2 Depletion Interferes with Development by Disrupting the Cell Cycle
por: Mönnich, Maren, et al.
Publicado: (2011)

The Transcriptional Targets of Mutant FOXL2 in Granulosa Cell Tumours
por: Rosario, Roseanne, et al.
Publicado: (2012)

Intrinsic subtypes in Ethiopian breast cancer patient
por: Desalegn, Zelalem, et al.
Publicado: (2022)

Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy
por: Takamatsu, Shiro, et al.
Publicado: (2022)

A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies
por: Wang, Chunyan, et al.
Publicado: (2021)

The challenge of studying complex diseases undergoing complex treatments: the metastatic cancer model
por: Wang, Ena, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_72a6qcbv2qtmulv939laq83trc